What AI says about Orphan Reach | Parse

What AI says about Orphan Reach

Track Orphan Reach free

Data as of Oct 7, 2026Based on 441 AI responsesReviewed by Dimitry Apollonsky · Oct 5, 2026

See how Parse measures this

theemmesgroup.com

Emmes provides full-service clinical research delivery for rare disease treatments, focusing on patient-centered trial design and execution. The company offers expertise in orphan drug strategy, patient recruitment, and global operational support across over 100 countries.

The Emmes Group

Products

Orphan ReachThis page1%

Mentioned in

1%No change

of AI answers about Orphan Reach and its rivals. Since Jul 5

The market map

Biopharma Research Platforms and Services

Mentioned in

1Isomorphic Labs20% · Avg. position 29.2
2Rare Patient Voice18% · Avg. position 245.3
=3Insilico Medicine16% · Avg. position 13.3
=3Evolutionary Scale16% · Avg. position 40.0
=3Patiro16% · Avg. position 133.3
=3MedPanel16% · Avg. position 90.0
=3Recursion16% · Avg. position 136.1
=9NVIDIA13% · Avg. position 8.5
=9Luminex13% · Avg. position 7.3
=11Bioptimus12% · Avg. position 10.0
=11Quanterix Simoa12% · Avg. position 6.8
=11Precision for Medicine12% · Avg. position 5.1
=11Generate Biomedicines12% · Avg. position 10.3
15Msd11% · Avg. position 7.2
=67Orphan Reach2% · Avg. position 4.5

Orphan Reach in AI’s own words

Question: I need a patient recruitment agency that focuses on rare disease populations.

Google AI ModeAug 24, 2026

Orphan Reach : A contract research organization (CRO) with a dedicated Orphan Reach Rare Disease Focus

Ask Google AI Mode yourself (opens in a new tab)

How often AI mentions Orphan Reach

Aug 13SepOct 1

Where AI names Orphan Reach

Since Jul 5

ChatGPT Search0%
Google AI Mode

Topics AI recommends Orphan Reach for1

Orphan Reach's share in each topic, as its page ranks it

Topic#

Rare disease patient recruitmentBiopharma Research Platforms and Services9%=15

Other brands in Biopharma Research Platforms and Services

Rank